Ads
related to: tecentriq (atezolizumab)- TECENTRIQ® Videos
Watch The Video Series & Learn How
TECENTRIQ® Might Help. Watch Now.
- Clinical & Efficacy Info
Discover Clinical Trial & Clinical
Study Results On TECENTRIQ®.
- Financial Support
Find Financial Support Options For
Your Patients On TECENTRIQ®.
- Register for Updates
Sign Up For Updates About
TECENTRIQ®. Visit Website.
- TECENTRIQ® Videos
Search results
Roche's (RHHBY) Tecentriq Subcutaneous Gets Approval in the EU
Zacks via Yahoo Finance· 4 months agoRoche RHHBY announced that the European Commission has granted marketing authorization to...
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
Benzinga via Yahoo Finance· 1 year agoGenentech, a unit of Roche Holdings AG (OTC: RHHBY), announced that the Phase 3 IMbrave050 study met...
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
Benzinga via Yahoo Finance· 1 year agoExelixis Inc (NASDAQ: EXEL) announced that the CONTACT-01 study did not meet its primary endpoint of...
Biotech Stock Roundup: PTGX Gains on Study Data, BMRN Faces Setback & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with key pipeline and regulatory updates. Among these, BMRN was down...
Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern
Benzinga via Yahoo Finance· 2 years agoAmgen Inc (NASDAQ: AMGN) announced new data sets from its thoracic oncology portfolio, including new...
Roche (RHHBY) Announces Data on Tecentriq Combo for HCC
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) new data from the late-stage IMbrave050 study reveals that the combination of...
Exelixis' (EXEL) Cabozantinib Combo Study Fails to Meet Goal
Zacks via Yahoo Finance· 1 year agoShares of Exelixis, Inc. EXEL were down 0.17% on Mar 3 after the company announced the failure of...
Roche (RHHBY) Up on Upbeat Data From Combo Drug Cancer Study
Zacks via Yahoo Finance· 9 months agoRoche's (RHHBY) stock jumps 4.3% on Wednesday after the company inadvertently publishes encouraging...
Exelixis' (EXEL) Prostate Cancer Study Meets Primary Endpoint
Zacks via Yahoo Finance· 9 months agoExelixis, Inc. EXEL and partner Ipsen announced that the late-stage CONTACT-02 study achieved one of...
Biotech Stocks Rally After Roche's (RHHBY) Accidental Data Leak
Zacks via Yahoo Finance· 9 months agoOn Aug 23, shares of several biotech companies rose after pharma-giant Roche‘s RHHBY stated that it...
Ads
related to: tecentriq (atezolizumab)